Wall Street Journal

U.S. Seeks Large-Scale Expansion of Blood-Plasma Collection for Covid-19

A growing number of hospitals are investigating antibody testing and blood plasma therapy as a way to combat the new coronavirus in sick patients. WSJ’s Daniela Hernandez explains. Photo illustration: ...
FierceBiotech

Tasso secures $17M to scale up home blood testing devices in the face of COVID-19

Tasso has received $17 million in new funding to scale up production of its self-administered blood collection devices, designed to help enable telemedicine and diagnostic testing from the home. The ...
FierceBiotech

Tasso draws up $100M to advance at-home blood collection devices

After the earliest stages of the COVID-19 pandemic illustrated how important access to healthcare outside the hospital can be, several companies have worked to make that access part of the new normal.
Business Wire

Tasso Secures $17 Million Series A Financing to Scale Production of At-Home Blood Collection Systems and Capitalize on Growing Demand for Remote Diagnostic Testing

SEATTLE--(BUSINESS WIRE)--Tasso Inc., a pioneer in clinical-grade, at-home, self-sampling blood collection, today announced it has completed an oversubscribed $17 million Series A financing round. The ...
Healio

Examining the blood collection experience

Modern blood testing is the foundation of clinical screening and decision-making. Timely disease diagnosis, prevention and chronic care management depend on accurate diagnostic testing. More than 7 ...